{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:06:39Z","timestamp":1792109199381,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016126","name":"Beijing Hospital Authority","doi-asserted-by":"publisher","award":["DFL20191802"],"award-info":[{"award-number":["DFL20191802"]}],"id":[{"id":"10.13039\/100016126","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672000"],"award-info":[{"award-number":["81672000"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002799","name":"Capital Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["Z191100006619045"],"award-info":[{"award-number":["Z191100006619045"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010270","name":"Capital Health Research and Development of Special Fund","doi-asserted-by":"publisher","award":["2020-2-2174"],"award-info":[{"award-number":["2020-2-2174"]}],"id":[{"id":"10.13039\/501100010270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jgar.2022.01.017","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:33:16Z","timestamp":1643416396000},"page":"241-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Prevalence of transmitted drug resistance among ART-na\u00efve HIV-infected individuals, Beijing, 2015\u20132018"],"prefix":"10.1016","volume":"28","author":[{"given":"Rui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5988-5531","authenticated-orcid":false,"given":"Danying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuilin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5266-033X","authenticated-orcid":false,"given":"Junyan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2022.01.017_bib0001","unstructured":"https:\/\/www.avert.org\/professionals\/hiv-around-world\/asia-pacific\/china; 11 June 2019."},{"key":"10.1016\/j.jgar.2022.01.017_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101738","article-title":"Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic","volume":"9","author":"Pineda-Pena","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2022.01.017_bib0003","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(12)61038-1","article-title":"Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis","volume":"380","author":"Gupta","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2022.01.017_bib0004","article-title":"Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014\u20132015","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2022.01.017_bib0005","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s00705-018-3825-7","article-title":"Surveillance of HIV-1 drug resistance in Xinjiang: high prevalence of K103N in treatment-naive individuals","volume":"163","author":"Shu","year":"2018","journal-title":"Arch Virol"},{"key":"10.1016\/j.jgar.2022.01.017_bib0006","unstructured":"World Health Organization. HIV drug resistance report 2019. https:\/\/www.whoint\/publications\/i\/item\/WHO-CDS-HIV-1921. 1 July 2019."},{"key":"10.1016\/j.jgar.2022.01.017_bib0007","first-page":"22","article-title":"Prevalence of transmitted HIV-1 drug resistance (TDR) associated mutations and predicted drug sensitivity in newly diagnosed HIV-1 patient cohort in a western New York, 2005\u20132011","volume":"6","author":"Dai","year":"2014","journal-title":"J Antivir Antiretrovir"},{"key":"10.1016\/j.jgar.2022.01.017_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2019.100251","article-title":"Following the path: Increasing trends of HIV-1 drug resistance in China","volume":"18","author":"Gupta","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jgar.2022.01.017_bib0009","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/cid\/civ963","article-title":"Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe","volume":"62","author":"Hofstra","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2022.01.017_bib0010","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/cid\/ciw382","article-title":"Transmitted HIV drug resistance is high and longstanding in metropolitan Washington, DC","volume":"63","author":"Kassaye","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2022.01.017_bib0011","first-page":"17","article-title":"Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world","volume":"14","author":"Frentz","year":"2012","journal-title":"AIDS Rev"},{"key":"10.1016\/j.jgar.2022.01.017_bib0012","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1473-3099(17)30702-8","article-title":"HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis","volume":"18","author":"Gupta","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2022.01.017_bib0013","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1089\/aid.2011.0097","article-title":"The prevalence of drug resistance mutations among treatment-naive HIV-infected individuals in Beijing, China","volume":"28","author":"Ye","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jgar.2022.01.017_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230779","article-title":"Characterization of subtypes and transmitted drug resistance strains of HIV among Beijing residents between 2001-2016","volume":"15","author":"Ye","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2022.01.017_bib0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijid.2019.12.001","article-title":"HIV-1 low-level viremia affects T cell activation rather than T cell development in school-age children, adolescents, and young adults during antiretroviral therapy","volume":"91","author":"Han","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jgar.2022.01.017_bib0016","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/QAD.0000000000002468","article-title":"Transmitted HIV drug resistance among individuals with newly diagnosed HIV infection: a multicenter observational study","volume":"34","author":"Ye","year":"2020","journal-title":"AIDS"},{"key":"10.1016\/j.jgar.2022.01.017_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206234","article-title":"Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: results from the national molecular surveillance of new HIV-diagnoses","volume":"13","author":"Hauser","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2022.01.017_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2019.100238","article-title":"Trend of HIV-1 drug resistance in China: a systematic review and meta-analysis of data accumulated over 17 years (2001\u20132017)","volume":"18","author":"Zuo","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jgar.2022.01.017_bib0019","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11904-019-00478-x","article-title":"Optimizing treatment for adults with HIV\/AIDS in China: successes over two decades and remaining challenges","volume":"17","author":"Cao","year":"2020","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.jgar.2022.01.017_bib0020","first-page":"867","article-title":"Society of Infectious Diseases, Chinese Medical Association; Chinese Center for Disease Control and Prevention [Chinese guidelines for diagnosis and treatment of HIV\/AIDS (2018)]","volume":"57","year":"2018","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.jgar.2022.01.017_bib0021","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1089\/vim.2014.0025","article-title":"Transmitted antiretroviral drug resistance in the men who have sex with men HIV patient cohort, Beijing, China, 2008\u20132011","volume":"27","author":"Dai","year":"2014","journal-title":"Viral Immunol"},{"key":"10.1016\/j.jgar.2022.01.017_bib0022","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/hiv.12878","article-title":"2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0","volume":"21","author":"Ryom","year":"2020","journal-title":"HIV Med"},{"key":"10.1016\/j.jgar.2022.01.017_bib0023","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(06)69158-7","article-title":"The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings","volume":"368","author":"Gilks","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2022.01.017_bib0024","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jmii.2014.08.002","article-title":"Prevalence and associated factors for HIV-1 transmitted drug resistance in voluntary clients for counseling and testing in Southern Taiwan","volume":"49","author":"Weng","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jgar.2022.01.017_bib0025","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1186\/s12879-014-0689-7","article-title":"HIV-1 transmitted drug resistance-associated mutations and mutation co-variation in HIV-1 treatment-naive MSM from 2011 to 2013 in Beijing, China","volume":"14","author":"Jiao","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2022.01.017_bib0026","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1017\/S0950268817003016","article-title":"Prevalence of transmitted drug resistance among HIV-1 treatment-naive patients in Beijing","volume":"146","author":"Song","year":"2018","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jgar.2022.01.017_bib0027","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12879-019-3927-1","article-title":"Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2022.01.017_bib0028","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1097\/QAD.0000000000002282","article-title":"Lack of HIV-1 integrase inhibitor resistance among 392 antiretroviral-naive individuals in a tertiary care hospital in Beijing, China","volume":"33","author":"Liu","year":"2019","journal-title":"AIDS"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716522000212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716522000212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:00:01Z","timestamp":1761991201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716522000212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":28,"alternative-id":["S2213716522000212"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2022.01.017","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of transmitted drug resistance among ART-na\u00efve HIV-infected individuals, Beijing, 2015\u20132018","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2022.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}